10x Genomics Price to Sales Ratio 2018-2024 | TXG

Historical PS ratio values for 10x Genomics (TXG) over the last 10 years. The current P/S ratio for 10x Genomics as of May 01, 2024 is . For more information on how our historical price data is adjusted see the Stock Price Adjustment Guide.
10x Genomics P/S Ratio Historical Data
Date Stock Price TTM Sales per Share Price to Sales Ratio
2024-05-01 26.92 5.07
2024-03-31 37.53 $5.31 7.06
2023-12-31 55.96 $5.29 10.57
2023-09-30 41.25 $5.10 8.09
2023-06-30 55.84 $4.94 11.30
2023-03-31 55.79 $4.69 11.89
2022-12-31 36.44 $4.54 8.02
2022-09-30 28.48 $4.47 6.37
2022-06-30 45.25 $4.45 10.16
2022-03-31 76.07 $4.50 16.91
2021-12-31 148.96 $4.46 33.41
2021-09-30 145.58 $4.27 34.12
2021-06-30 195.82 $3.85 50.92
2021-03-31 181.00 $3.22 56.13
2020-12-31 141.60 $2.99 47.29
2020-09-30 124.68 $2.67 46.72
2020-06-30 89.31 $4.06 22.01
Sector Industry Market Cap Revenue
Medical Medical Information Systems $3.489B $0.619B
10x Genomics Inc. is a life science technology company. It develops and sells instruments, consumables and software for analyzing biological systems. 10x Genomics Inc. is based in Pleasanton, California.
Stock Name Country Market Cap PE Ratio
GE HealthCare Technologies (GEHC) United States $34.790B 19.11
Inspire Medical Systems (INSP) United States $7.322B 0.00
IRhythm Technologies (IRTC) United States $3.410B 0.00
Axonics (AXNX) United States $3.396B 0.00
Enovis (ENOV) United States $3.029B 23.01
Azenta (AZTA) United States $2.925B 238.46
Olink Holding AB (publ) (OLK) Sweden $2.864B 0.00
Hims & Hers Health (HIMS) United States $2.685B 0.00
Privia Health (PRVA) United States $2.183B 96.84
Schrodinger (SDGR) United States $1.763B 0.00
Omnicell (OMCL) United States $1.231B 30.12
Phreesia (PHR) United States $1.169B 0.00
Definitive Healthcare (DH) United States $0.817B 0.00
Mobile-health Network Solutions (MNDR) Singapore $0.783B 0.00
Standard BioTools (LAB) United States $0.719B 0.00
Fulgent Genetics (FLGT) United States $0.608B 0.00
Talkspace (TALK) United States $0.519B 0.00
Health Catalyst (HCAT) United States $0.367B 0.00
SOPHiA GENETICS SA (SOPH) Switzerland $0.333B 0.00
Clover Health Investments (CLOV) United States $0.312B 0.00
Pulmonx (LUNG) United States $0.293B 0.00
P3 Health Partners (PIII) United States $0.170B 0.00
Butterfly Network (BFLY) United States $0.162B 0.00
American Well (AMWL) United States $0.148B 0.00
MSP Recovery (LIFW) United States $0.139B 0.00
Augmedix (AUGX) United States $0.133B 0.00
Outset Medical (OM) United States $0.131B 0.00
TruBridge (TBRG) United States $0.116B 4.94
111 (YI) China $0.087B 0.00
Future Health ESG (FHLT) United States $0.073B 0.00
SHL Telemedicine (SHLT) Israel $0.071B 0.00
HeartBeam (BEAT) United States $0.053B 0.00
Zepp Health (ZEPP) China $0.052B 0.00
EUDA Health Holdings (EUDA) Singapore $0.047B 0.00
Movano (MOVE) United States $0.044B 0.00
ImmunoPrecise Antibodies (IPA) Canada $0.034B 0.00
Akili (AKLI) United States $0.031B 0.00
Bullfrog AI Holdings (BFRG) United States $0.025B 0.00
Cue Health (HLTH) United States $0.022B 0.00
CareCloud (CCLD) United States $0.018B 0.00
Streamline Health Solutions (STRM) United States $0.018B 0.00
ETAO (ETAO) United States $0.016B 0.00
Strata Skin Sciences (SSKN) United States $0.014B 0.00
Biotricity (BTCY) United States $0.013B 0.00
Transgenomic (PRPO) United States $0.008B 0.00
HeartSciences (HSCS) United States $0.006B 0.00
Syra Health (SYRA) United States $0.006B 0.00
Predictive Oncology (POAI) United States $0.006B 0.00
Healthcare Triangle (HCTI) United States $0.006B 0.00
Zhongchao (ZCMD) China $0.003B 0.00
Tivic Health Systems (TIVC) United States $0.002B 0.00
Centogene (CNTG) Germany $0.000B 0.00
MDxHealth SA (MDXH) Belgium $0.000B 0.00
Nyxoah SA (NYXH) Belgium $0.000B 0.00